Dithiolethiones D3T and ACDT Protect Against Iron Overload-Induced Cytotoxicity and Serve as Ferroptosis Inhibitors in U-87 MG Cells
- PMID: 37061657
- DOI: 10.1007/s11064-023-03927-7
Dithiolethiones D3T and ACDT Protect Against Iron Overload-Induced Cytotoxicity and Serve as Ferroptosis Inhibitors in U-87 MG Cells
Abstract
Iron overload-induced oxidative stress is implicated in various neurodegenerative disorders. Given the numerous adverse effects associated with current iron chelators, natural antioxidants are being explored as alternative therapeutic options. Dithiolethiones found in cruciferous vegetables have emerged as promising candidates against a wide range of toxicants owing to their lipophilic and cytoprotective properties. Here, we test the dithiolethiones 3H-1,2-dithiole-3-thione (D3T) and 5-amino-3-thioxo-3H-(1,2) dithiole-4-carboxylic acid ethyl ester (ACDT) against ferric ammonium citrate (FAC)-induced toxicity in U-87 MG astrocytoma cells. Exposure to 15 mM FAC for 24 h resulted in 54% cell death. A 24-h pretreatment with 50 μM D3T and ACDT prevented this cytotoxicity. Both dithiolethiones exhibited antioxidant effects by activating the nuclear factor erythroid 2-related factor-2 (Nrf2) transcription factor and upregulating levels of intracellular glutathione (GSH). This resulted in the successful inhibition of FAC-induced reactive oxygen species, lipid peroxidation, and cell death. Additionally, D3T and ACDT upregulated expression of the Nrf2-mediated iron storage protein ferritin which consequently reduced the total labile iron pool. A 24-h pretreatment with D3T and ACDT also prevented cell death induced by the ferroptosis inducer erastin by upregulating the transmembrane cystine/glutamate antiporter (xCT) expression. The resulting increase in intracellular GSH and alleviation of lipid peroxidation was comparable to that caused by ferrostatin-1, a specific ferroptosis inhibitor. Collectively, our findings demonstrate that dithiolethiones may show promise as potential therapeutic options for the treatment of iron overload disorders.
Keywords: Antioxidants; Dithiolethiones; Ferroptosis; Iron overload; Oxidative stress.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Disubstituted Dithiolethione ACDT Exerts Neuroprotective Effects Against 6-Hydroxydopamine-Induced Oxidative Stress in SH-SY5Y Cells.Neurochem Res. 2019 Aug;44(8):1878-1892. doi: 10.1007/s11064-019-02823-3. Epub 2019 Jun 4. Neurochem Res. 2019. PMID: 31190314
-
Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.Mol Med. 2001 Feb;7(2):135-45. Mol Med. 2001. PMID: 11471548 Free PMC article.
-
Neuroprotective effects of disubstituted dithiolethione ACDT against manganese-induced toxicity in SH-SY5Y cells.Neurochem Int. 2021 Jul;147:105052. doi: 10.1016/j.neuint.2021.105052. Epub 2021 Apr 24. Neurochem Int. 2021. PMID: 33905764
-
Programmed Cell-Death by Ferroptosis: Antioxidants as Mitigators.Int J Mol Sci. 2019 Oct 8;20(19):4968. doi: 10.3390/ijms20194968. Int J Mol Sci. 2019. PMID: 31597407 Free PMC article. Review.
-
Future Perspectives of Oxytosis/Ferroptosis Research in Neurodegeneration Diseases.Cell Mol Neurobiol. 2023 Aug;43(6):2761-2768. doi: 10.1007/s10571-023-01353-5. Epub 2023 Apr 24. Cell Mol Neurobiol. 2023. PMID: 37093436 Free PMC article. Review.
Cited by
-
Advances in Ferroptosis Research: A Comprehensive Review of Mechanism Exploration, Drug Development, and Disease Treatment.Pharmaceuticals (Basel). 2025 Feb 26;18(3):334. doi: 10.3390/ph18030334. Pharmaceuticals (Basel). 2025. PMID: 40143112 Free PMC article. Review.
-
Metabolic Derangement of Essential Transition Metals and Potential Antioxidant Therapies.Int J Mol Sci. 2024 Jul 18;25(14):7880. doi: 10.3390/ijms25147880. Int J Mol Sci. 2024. PMID: 39063122 Free PMC article. Review.
-
Ferroptosis inhibitors: past, present and future.Front Pharmacol. 2024 May 23;15:1407335. doi: 10.3389/fphar.2024.1407335. eCollection 2024. Front Pharmacol. 2024. PMID: 38846099 Free PMC article. Review.
References
-
- Youssef LA, Spitalnik SL (2017) Iron: a double-edged sword. Transfusion 57(10):2293–2297. https://doi.org/10.1111/trf.14296 - DOI - PubMed - PMC
-
- Jaishankar M, Tseten T, Anbalagan N, Mathew BB, Beeregowda KN (2014) Toxicity, mechanism and health effects of some heavy metals. Interdiscip Toxicol 7(2):60–72. https://doi.org/10.2478/intox-2014-0009 - DOI - PubMed - PMC
-
- Li K, Reichmann H (2016) Role of iron in neurodegenerative diseases. J Neural Transm (Vienna) 123(4):389–399. https://doi.org/10.1007/s00702-016-1508-7 - DOI - PubMed
-
- Sian-Hulsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson’s disease. J Neurochem 118(6):939–957. https://doi.org/10.1111/j.1471-4159.2010.07132.x - DOI - PubMed
-
- Gordon N (2000) Friedreich’s ataxia and iron metabolism. Brain Dev 22(8):465–468. https://doi.org/10.1016/s0387-7604(00)00175-3 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
